SEARCH BY
| Category | Company |
|---|---|
| Founded | 2005 |
| Sector | Life Science |
| Employees | 176 |
| Revenue | 27M EUR (2016) |
Biosynex is a designer and distribution of rapid diagnostic tests. Biosynex develops, manufactures and markets Medical Devices for Screening, Diagnostics, and Prevention in a permanent quest for excellence. Biosynex was founded in 2008 and is based in Illkirch-Graffenstaden, France.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 5 |
| Sector: Medical Products M&A | 2 of 4 |
| Type: Add-on Acquisition M&A Deals | 1 of 2 |
| Country: France M&A | 2 of 3 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-12-04 |
Visiomed Group SA - Family Health Activities
Paris, France Visiomed Group SA - Family Health Activities includes medical devices and non-connected pharmacy products. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-01-31 |
Chembio Diagnostics
Hauppauge, New York, United States Chembio Diagnostics is a developer, manufacturer and marketer of proprietary rapid diagnostic tests in the growing $8.0 billion point-of-care testing market. Chembio markets each of its DPP® HIV 1/2 Assay, HIV 1/2 STAT-PAK® Assay, and SURE CHECK® HIV 1/2 Assay, with these Chembio brand names, in the U.S. and internationally both directly and through third-party distributors. Chembio Diagnostics was incorporated in 1985 and is based in Hauppauge, New York. |
Buy | $17M |
